Nicholas C. Yoder
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Monoclonal and Polyclonal Antibodies Research, CAR-T cell therapy research, Peptidase Inhibition and Analysis, 14-3-3 protein interactions
Most-Cited Works
- → Fluorinated amino acids in protein design and engineering(2002)314 cited
- → Site-Specific N- and C-Terminal Labeling of a Single Polypeptide Using Sortases of Different Specificity(2009)249 cited
- → Effects of Drug–Antibody Ratio on Pharmacokinetics, Biodistribution, Efficacy, and Tolerability of Antibody–Maytansinoid Conjugates(2017)245 cited
- → A CD123-targeting antibody-drug conjugate, IMGN632, designed to eradicate AML while sparing normal bone marrow cells(2018)174 cited
- → Preparation of unnatural N-to-N and C-to-C protein fusions(2012)136 cited
- → Understanding How the Stability of the Thiol-Maleimide Linkage Impacts the Pharmacokinetics of Lysine-Linked Antibody–Maytansinoid Conjugates(2016)76 cited
- → Bioorthogonal noncovalent chemistry: fluorous phases in chemical biology(2006)59 cited
- → A DNA-Interacting Payload Designed to Eliminate Cross-Linking Improves the Therapeutic Index of Antibody–Drug Conjugates (ADCs)(2018)53 cited
- → Discovery and Optimization of HKT288, a Cadherin-6–Targeting ADC for the Treatment of Ovarian and Renal Cancers(2017)52 cited
- → The chlamydial OTU domain-containing proteinChlaOTU is an early type III secretion effector targeting ubiquitin and NDP52(2013)46 cited